Long-term typhoid vaccine protection study in Indonesia
Part of Infections clinical trials.
This study is checking how long the protection from a typhoid vaccine (called Bio TCV) lasts in people in Indonesia, compared to another vaccine. You would need to provide blood samples over time to see if your protection is still strong.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be in good general health.
- You (or your parent/guardian, if you are a minor) must be willing to sign a consent form.
- You must be able to follow the study instructions and attend scheduled visits.
- You must not have a bleeding disorder or blood condition that makes blood draws risky.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new combined vaccine that protects against six diseases (diphtheria, tetanus, whooping cough, hepatitis B, Hib, and polio) in Indonesian infants. It aims to see if it is safe and produces a good immune response.
This study tests new ways to diagnose tuberculosis (TB) in both children and adults who have symptoms like a long-lasting cough. It aims to find better tools to detect TB early and help people get the right treatment faster.
This study tests a new typhoid vaccine (called ZyVac-TCV) in children and adolescents. It aims to protect them from typhoid fever, a serious bacterial infection, and will compare the vaccine to the usual care.
This study tests a new vaccine that could protect infants against typhoid fever and a serious type of salmonella. If your baby is healthy and within the age range, they may be eligible to participate.
This study gives (or follows) typhoid and/or cholera vaccines and measures how your immune system responds. It is done in adults who are already scheduled for an upper endoscopy (EGD) and/or colonoscopy, using small tissue samples if appropriate.
This study looks at how your body's immune system responds to the yellow fever vaccine. It may help researchers understand how well the vaccine protects people.
Hear when a new Antibody Typhoid Vaccine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.